Statins may protect against acute cholangitis in primary sclerosing cholangitis
SAN DIEGO — Statin therapy decreased the risk for developing acute cholangitis among patients with primary sclerosing cholangitis, according to research presented at Digestive Disease Week 2022.“Primary sclerosing cholangitis [PSC] is a cholestatic biliary disease whose analysis and underlying biology remains fairly poorly understood,” Chiraag Kulkarni, MD, internal medicine specialist at Stanford University, said. “The complications of PSC are the development of acute cholecystitis, significantly elevated risk for GI malignancy and the development of cirrhosis, andRead More
